Sven Trelle

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study	2020	Benjamin Kasenda Junhao Liu Yu Jiang Byron J. Gajewski Cen Wu Erik von Elm Stefan Schandelmaier Giusi Moffa Sven Trelle Andreas M. Schmitt
+	Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study [study protocol].	2020	Benjamin Kasenda Junhao Liu Yu Jiang Byron J. Gajewski Cen Wu Erik von Elm Stefan Schandelmaier Giusi Moffa Sven Trelle Andreas M. Schmitt
+ PDF Chat	Synthesizing existing evidence to design future trials: survey of methodologists from European institutions	2019	Adriani Nikolakopoulou Sven Trelle Alex J. Sutton Matthias Egger Georgia Salanti
+ PDF Chat	Planning a future randomized clinical trial based on a network of relevant past trials	2018	Georgia Salanti Adriani Nikolakopoulou Alex J. Sutton Stephan Reichenbach Sven Trelle Huseyin Naci Matthias Egger
+ PDF Chat	Planning a future randomized clinical trial based on a network of relevant past trials	2018	Georgia Salanti Adriani Nikolakopoulou Alex J. Sutton Stephan Reichenbach Sven Trelle Huseyin Naci Matthias Egger
+ PDF Chat	A model for meta-analysis of correlated binary outcomes: The case of split-body interventions	2017	Orestis Efthimiou Dimitris Mavridis Adriani Nikolakopoulou Gerta Rücker Sven Trelle Matthias Egger Georgia Salanti
+	Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world	2017	Paco M J Welsing Katrien Oude Rengerink Sue Collier Laurent Eckert Maarten van Smeden Antonio Ciaglia Gaëlle Nachbaur Sven Trelle Aliki Taylor Matthias Egger
+ PDF Chat	Exploratory trials in mental health: anything to learn from other disciplines?	2017	Sven Trelle
+	GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world	2016	Klea Panayidou Sandro Gsteiger Matthias Egger Gablu Kilcher Máximo Carreras Orestis Efthimiou Thomas P. A. Debray Sven Trelle Noemi Hummel
+	GetReal in network meta‐analysis: a review of the methodology	2016	Orestis Efthimiou Thomas P. A. Debray Gert van Valkenhoef Sven Trelle Klea Panayidou Karel G.M. Moons Johannes B. Reitsma Aijing Shang Georgia Salanti
+ PDF Chat	Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial	2015	Ana María Henao-Restrepo Ira M. Longini Matthias Egger Natalie E. Dean W. John Edmunds Anton Camacho Miles W. Carroll Moussa Doumbia Bertrand Draguez Sophie Duraffour
+	Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study	2013	Bruno R. da Costa Eveline Nüesch Anne WS Rutjes Bradley C. Johnston Stephan Reichenbach Sven Trelle Gordon Guyatt Peter Jüni
+	The importance of allocation concealment and patient blinding in osteoarthritis trials: A meta‐epidemiologic study	2009	Eveline Nüesch Stephan Reichenbach Sven Trelle Anne WS Rutjes Katharina Liewald Rebekka Sterchi Douglas G. Altman Peter Jüni
+	High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data	2009	H. Schulz Corinne Brillant Guido Schwarzer Sven Trelle Alexander Greb Julia Bohlius Andreas Engert
+ PDF Chat	Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals	2006	Thilo Kober Sven Trelle Andreas Engert

Common Coauthors

Coauthor	Papers Together
Matthias Egger	7
Georgia Salanti	5
Stephan Reichenbach	4
Alex J. Sutton	3
Orestis Efthimiou	3
Lars G. Hemkens	2
Stefan Schandelmaier	2
Peter Jüni	2
Erik von Elm	2
Klea Panayidou	2
Cen Wu	2
Giusi Moffa	2
Huseyin Naci	2
Adriani Nikolakopoulou	2
Deborah J. Cook	2
Amanda K. Herbrand	2
Eveline Nüesch	2
Anne WS Rutjes	2
Byron J. Gajewski	2
Kris McGill	2
Benjamin Kasenda	2
Anna‐Bettina Haidich	2
Jean‐Marc Tréluyer	2
Adriani Nikolakopoulou	2
Junhao Liu	2
Thomas P. A. Debray	2
Matthias Briel	2
Maureen O. Meade	2
John P. A. Ioannidis	2
Sally Hopewell	2
Benjamin Speich	2
Andreas M. Schmitt	2
Constantin Sluka	2
Viktoria Gloy	2
François Lamontagne	2
Shaun Treweek	2
Alpha Kabinet Keïta	1
Andreas Engert	1
Máximo Carreras	1
Miles W. Carroll	1
Ximena Riveros	1
Paco M J Welsing	1
Corinne Brillant	1
Yu Jiang	1
Sema Mandal	1
Thilo Kober	1
Karel G.M. Moons	1
Guido Schwarzer	1
Julia Bohlius	1
Dimitris Mavridis	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review	2013	Timothy Clark Ursula Berger Ulrich Mansmann	3
+	Planning future studies based on the precision of network meta‐analysis results	2015	Adriani Nikolakopoulou Dimitris Mavridis Georgia Salanti	3
+ PDF Chat	Planning future studies based on the conditional power of a meta‐analysis	2012	Verena Roloff Julian P. T. Higgins Alex J. Sutton	3
+	Using conditional power of network meta‐analysis (NMA) to inform the design of future clinical trials	2014	Adriani Nikolakopoulou Dimitris Mavridis Georgia Salanti	3
+	Assessing comparative effectiveness of new drugs before approval using prospective network meta-analyses	2013	Huseyin Naci Alec O'connor	3
+ PDF Chat	Evidence‐based sample size calculations based upon updated meta‐analysis	2006	Alex J. Sutton Nicola J. Cooper David R. Jones Paul C. Lambert John R. Thompson Keith R. Abrams	3
+	The BUGS project: Evolution, critique and future directions	2009	David J. Lunn David J. Spiegelhalter Andrew C. Thomas Nicky Best	2
+	Meta-analysis in clinical trials	1986	Rebecca DerSimonian Nan M. Laird	2
+	Correlation of Quality Measures With Estimates of Treatment Effect in Meta-analyses of Randomized Controlled Trials	2002	Ethan M. Balk	2
+ PDF Chat	Multivariate meta‐analysis: Potential and promise	2011	Dan Jackson Richard D. Riley Ian R. White	2
+	None	2000	David J. Lunn Andrew C. Thomas Nicky Best David J. Spiegelhalter	2
+	Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists	1995	David Moher Alejandro R. Jadad Graham Nichol Marie Penman Peter Tugwell Sharon Walsh	2
+	A practical introduction to multivariate meta-analysis	2012	Dimitris Mavridis Georgia Salanti	2
+	An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios	2014	Orestis Efthimiou Dimitris Mavridis Andrea Cipriani Stefan Leucht Pantelis G. Bagos Georgia Salanti	2
+ PDF Chat	Prevalence, Characteristics, and Publication of Discontinued Randomized Trials	2014	Benjamin Kasenda Erik von Elm John J. You Anette Blümle Yuki Tomonaga Ramon Saccilotto Alain Amstutz Theresa Bengough Joerg J Meerpohl Mihaela Stegert	2
+	Explanatory and Pragmatic Attitudes in Therapeutical Trials	2009	Daniel Schwartz J Lellouch	1
+ PDF Chat	Assessing key assumptions of network meta‐analysis: a review of methods	2013	Sarah Donegan Paula Williamson Umberto D’Alessandro Catrin Tudur Smith	1
+	Design and Analysis of Cluster Randomization Trials in Health Research	2000	Allan Donner Neil Klar	1
+ PDF Chat	Optimal multistage designs for randomised clinical trials with continuous outcomes	2011	James Wason Adrian Mander Simon G. Thompson	1
+ PDF Chat	Assessing Evidence Inconsistency in Mixed Treatment Comparisons	2006	Guobing Lu A. E. Ades	1
+ PDF Chat	Predictive distributions for between‐study heterogeneity and simple methods for their application in Bayesian meta‐analysis	2014	Rebecca M. Turner Dan Jackson Yinghui Wei Simon G. Thompson Julian P. T. Higgins	1
+	Robust tests for equality of variances	1961	Howard Levene	1
+	The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?	2007	Jocelyn Gravel Lucie Opatrny Stan Shapiro	1
+	Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5	2012	Richard Pitman David N. Fisman Gregory S. Zaric Maarten J. Postma Mirjam Kretzschmar John Edmunds Marc Brisson	1
+ PDF Chat	The effects of excluding treatments from network meta-analyses: survey	2013	Edward J. Mills Steve Kanters Kristian Thorlund Anna Chaimani Areti‐Angeliki Veroniki John P. A. Ioannidis	1
+ PDF Chat	Multiplicative interaction in network meta‐analysis	2014	Hans‐Peter Piepho L. V. Madden Emlyn Williams	1
+ PDF Chat	Increasing value and reducing waste in research design, conduct, and analysis	2014	John P. A. Ioannidis Sander Greenland Mark A. Hlatky Muin J. Khoury Malcolm Macleod David Moher Kenneth F. Schulz Robert Tibshirani	1
+	Patterns of patient enrollment in randomized controlled trials	2001	Anna‐Bettina Haidich John P. A. Ioannidis	1
+ PDF Chat	Optimal three-stage designs for phase II cancer clinical trials	1997	T. Timothy Chen	1
+	Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials	1995	John Bryant Roger Day	1
+	Using Indirect Evidence to Determine the Comparative Effectiveness of Prescription Drugs: Do Benefits Outweigh Risks?	2011	Huseyin Naci Rachael Fleurence	1
+ PDF Chat	Bayesian network meta-analysis for unordered categorical outcomes with incomplete data	2013	Christopher H. Schmid Thomas A Trikalinos Ingram Olkin	1
+ PDF Chat	Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making	2013	Shannon Cope Jeroen P. Jansen	1
+	Simpson’s Paradox From Adding Constants in Contingency Tables as an Example of Bayesian Noncollapsibility	2010	Sander Greenland	1
+ PDF Chat	The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?	2002	Stuart G. Baker Barnett S. Kramer	1
+	Mixed and Indirect Treatment Comparisons	2012	Nicky J. Welton Alex J. Sutton Nicola J. Cooper Keith R. Abrams A. E. Ades	1
+ PDF Chat	Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution?	2013	Kristian Thorlund Lehana Thabane Edward J. Mills	1
+	Choice of effect measure for epidemiological data	2000	Stephen D. Walter	1
+ PDF Chat	Determining the reporting quality of RCTs in clinical pharmacology	2004	Edward J. Mills Yoon K. Loke Ping Wu Víctor M. Montori Daniel Perri David Moher Gordon Guyatt	1
+	False Positive Rates of Randomized Phase II Designs	1999	P.Y Liu Michael LeBlanc Manisha Desai	1
+	Indirect comparison: relative risk fallacies and odds solution	2009	Simon Eckermann Michael Coory Andrew R. Willan	1
+ PDF Chat	The use of continuous data versus binary data in MTC models: A case study in rheumatoid arthritis	2012	Susanne Schmitz Róisín Adams Cathal Walsh	1
+ PDF Chat	Multiple treatment comparison meta-analyses: a step forward into complexity	2011	Edward Mills Nick Bansback Ghement Tholund Steven Kelly Milo A. Puhan James R. Wright	1
+	No Head-to-Head Trial? Simulate the Missing Arms	2010	J. Jaime K. Jack Ishak	1
+	Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons	2013	Hwanhee Hong Bradley P. Carlin Tatyana Shamliyan Jean F. Wyman Rema Ramakrishnan François Sainfort Robert L Kane	1
+ PDF Chat	Synthesis of Evidence On Heterogeneous Interventions with Multiple Outcomes Recorded Over Multiple Follow-Up Times Reported Inconsistently: A Smoking Cessation Case-Study	2013	Jason Madan Yen‐Fu Chen Paul Aveyard Dechao Wang Ismail Yahaya Marcus R. Munafò Linda Bauld Nicky J. Welton	1
+ PDF Chat	Between-Arm Comparisons in Randomized Phase II Trials	2009	Sin‐Ho Jung Stephen L. George	1
+	Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification	1986	John M. Lachin Mary A. Foulkes	1
+	Frequency of Treatment-Effect Modification Affecting Indirect Comparisons	2010	Michael Coory Susan J. Jordan	1
+	Design and Analysis of Cluster Randomization Trials in Health Research	2001	William W. Davis	1